BioSpace News Archive

Business

Optibrium and University of Nottingham Collaborate on Innovative Teaching Programme

Provides students with the opportunity to design new drug-like molecules targeting fibrotic diseases and malaria with cutting-edge drug discovery software

November 16, 2018
·
5 min read
Drug Development

Botanix treats first patient in BTX 1308 psoriasis patient study

Botanix has treated the first patient in its BTX 1308 psoriasis Phase 1b patient study

November 16, 2018
·
1 min read
Business

Immunicum AB (publ) Interim Report July - September 2018

Positive preclinical results presented at ESMO

November 16, 2018
·
5 min read
FDA

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease

Modus Therapeutics AB announces that the FDA has accepted its sevuparin IND for the treatment of SCD.

November 16, 2018
·
3 min read
Business

Expedeon AG signs supply and license agreement with Quanterix Corporation for access to proprietary immunoassay technology

Expedeon’s proprietary immunoassay technology to be incorporated into Quanterix’ Simoa Planar Immunoassay products

November 16, 2018
·
3 min read
Business

Epigenomics AG Announces 2018 Third Quarter and Nine Months Financial Results

Epigenomics AG today announced its financial results for the third quarter and the nine months 2018 ending September 30.

November 16, 2018
·
5 min read
Biotech Beach

Two Biotechs and One Medtech Make Deloitte’s Top 10 of the 2018 Fast 500 List

Two pharmaceutical companies and a medtech maker snagged three of the top-10 spots on Deloitte’s 2018 North America Technology Fast 500, a ranking of the fastest-growing North American companies in the fields of technology, life sciences, telecommunications, media and energy.

November 16, 2018
·
2 min read
·
Alex Keown
Business

Optimum Strategic Communications Appoints Leading Healthcare Investor Anne Marieke Ezendam

Renowned fund manager and buyside analyst joins investor relations and strategic communications specialists

November 16, 2018
·
4 min read
Business

Nebula Genomics Wants to Sequence Your Entire Genome for Free ... With One Little Catch

When consumers have their genome tested by services like 23andMe and Ancestry.com, the companies hold the rights to the genetic information, which they often sell to biopharmaceutical companies. Nebula Genomics is taking a different approach.

November 16, 2018
·
3 min read
·
Mark Terry
BioMidwest

Eli Lilly Could Sell Some Older China Assets for up to $300 Million

If the company does sell some older assets, it could use the funds to support development of high-growth assets in immuno-oncology.

November 16, 2018
·
2 min read
·
Alex Keown